News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,187 Results
Type
Article (25935)
Company Profile (60)
Press Release (356192)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (104264)
Career Advice (450)
Deals (16873)
Drug Delivery (51)
Drug Development (47598)
Employer Resources (47)
FDA (12265)
Job Trends (8443)
News (185936)
Policy (19425)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (26751)
ALS (57)
Alzheimer's disease (812)
Antibody-drug conjugate (ADC) (56)
Approvals (12327)
Artificial intelligence (172)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (40)
Bladder cancer (59)
Brain cancer (17)
Breast cancer (203)
Cancer (1461)
Cardiovascular disease (122)
Career advice (407)
Career pathing (13)
CAR-T (72)
Cell therapy (205)
Cervical cancer (14)
Clinical research (40564)
Collaboration (450)
Compensation (134)
Complete response letters (9)
COVID-19 (1493)
CRISPR (14)
C-suite (147)
Cystic fibrosis (43)
Data (1588)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (178)
Diagnostics (3527)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (55)
Drug shortages (21)
Duchenne muscular dystrophy (56)
Earnings (37091)
Editorial (22)
Employer branding (6)
Employer resources (44)
Events (51889)
Executive appointments (454)
FDA (13314)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (410)
Gene editing (40)
Generative AI (10)
Gene therapy (130)
GLP-1 (406)
Government (3038)
Grass and pollen (3)
Guidances (93)
Healthcare (12186)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (42)
Indications (19)
Infectious disease (1565)
Inflammatory bowel disease (82)
Inflation Reduction Act (4)
Influenza (27)
Intellectual property (51)
Interviews (40)
IPO (7043)
IRA (19)
Job creations (1840)
Job search strategy (378)
Kidney cancer (7)
Labor market (13)
Layoffs (172)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (234)
Lymphoma (100)
Machine learning (4)
Management (17)
Manufacturing (111)
MASH (53)
Medical device (12912)
Medtech (12915)
Mergers & acquisitions (10131)
Metabolic disorders (444)
Multiple sclerosis (55)
NASH (11)
Neurodegenerative disease (49)
Neuropsychiatric disorders (9)
Neuroscience (1151)
NextGen: Class of 2025 (3930)
Non-profit (2822)
Now hiring (17)
Obesity (221)
Opinion (70)
Ovarian cancer (56)
Pain (66)
Pancreatic cancer (56)
Parkinson's disease (90)
Partnered (11)
Patents (117)
Patient recruitment (84)
Peanut (37)
People (34739)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11617)
Phase II (17561)
Phase III (14428)
Pipeline (762)
Policy (62)
Postmarket research (1668)
Preclinical (3623)
Press Release (18)
Prostate cancer (77)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (186)
Real estate (2846)
Recruiting (16)
Regulatory (14232)
Reports (17)
Research institute (1607)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (52)
Series A (67)
Series B (50)
Service/supplier (3)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2121)
Stomach cancer (8)
Supply chain (38)
Tariffs (14)
The Weekly (8)
Vaccines (359)
Venture capitalists (13)
Weight loss (141)
Women's health (18)
Worklife (4)
Date
Today (13)
Last 7 days (474)
Last 30 days (1577)
Last 365 days (18262)
2025 (6375)
2024 (19849)
2023 (22737)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21195)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (119)
Arkansas (10)
Asia (24574)
Australia (3892)
California (3156)
Canada (1248)
China (378)
Colorado (167)
Connecticut (175)
Delaware (122)
Europe (48005)
Florida (562)
Georgia (129)
Idaho (33)
Illinois (364)
India (14)
Indiana (228)
Iowa (3)
Japan (125)
Kansas (74)
Kentucky (12)
Louisiana (8)
Maine (27)
Maryland (646)
Massachusetts (2197)
Michigan (108)
Minnesota (276)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (35)
New Hampshire (60)
New Jersey (1158)
New Mexico (9)
New York (981)
North Carolina (563)
North Dakota (4)
Northern California (1387)
Ohio (133)
Oklahoma (3)
Oregon (23)
Pennsylvania (851)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (23)
Southern California (1214)
Tennessee (79)
Texas (560)
United States (13133)
Utah (115)
Virginia (82)
Washington D.C. (42)
Washington State (231)
West Virginia (3)
Wisconsin (43)
382,187 Results for "acutus medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acutus Medical Reports Full Year 2024 Financial Results
March 24, 2025
·
8 min read
Business
Acutus Medical Reports First Quarter 2024 Financial Results
Acutus Medical, Inc. reported results for the first quarter of 2024.
May 9, 2024
·
8 min read
Business
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023.
April 1, 2024
·
11 min read
Press Releases
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
November 15, 2024
·
9 min read
Biotech Beach
Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring
Acutus Medical, Inc., announced a realignment of resources and corporate restructuring.
November 8, 2023
·
5 min read
Business
Acutus Medical Reports Third Quarter 2023 Financial Results
Acutus Medical, Inc. reported results for the third quarter of 2023.
November 8, 2023
·
13 min read
Business
Acutus Medical to Announce Third Quarter 2023 Financial Results
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2023 financial results on Monday, November 13, 2023.
November 2, 2023
·
1 min read
Business
Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
August 8, 2024
·
9 min read
Business
Acutus Medical Reports Second Quarter 2023 Financial Results
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2023.
August 7, 2023
·
14 min read
Business
Acutus Medical to Cancel Third Quarter 2023 Conference Call
Acutus Medical, Inc., announced that, following the Company’s announcement of its strategic realignment of resources and corporate restructuring and release of its third quarter results on November 8, 2023, the Company will no longer hold its third quarter results conference call and webcast which was previously scheduled for Monday, November 13, 2023.
November 10, 2023
·
1 min read
1 of 38,219
Next
